Canada markets closed

ZIVO Bioscience, Inc. (ZIVO)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
8.000.00 (0.00%)
At close: 12:46PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
27.65
0
0
20
Cost of Revenue
16.04
16.04
0
-
-
Gross Profit
11.61
11.61
0
-
-
Operating Expenses
Research Development
2,430
1,377
2,240
1,951
3,755
Selling General and Administrative
7,336
5,898
6,492
6,695
4,821
Total Operating Expenses
9,766
7,275
8,732
8,645
8,576
Operating Income or Loss
-9,766
-7,263
-8,732
-8,645
-8,556
Interest Expense
11.713
514.172
13.319
233.282
550.054
Total Other Income/Expenses Net
-
-
-
122.52
-
Income Before Tax
-9,777
-7,777
-8,745
-8,756
-9,106
Income from Continuing Operations
-9,777
-7,777
-8,745
-8,756
-9,106
Net Income
-9,777
-7,777
-8,745
-8,756
-9,106
Net Income available to common shareholders
-9,777
-7,777
-8,745
-8,756
-9,106
Basic EPS
-5.33
-
-5.57
-6.90
-10.58
Diluted EPS
-5.33
-
-5.57
-6.90
-10.58
Basic Average Shares
1,601
-
1,570
1,272
860.49
Diluted Average Shares
1,601
-
1,570
1,272
860.49